Drug Database
Back to search

France· FR:61649487

AMUKINE 0,06 %, solution pour application cutanée

A medicinal product containing solution d'hypochlorite de sodium, registered in France by GIFRER BARBEZAT.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAMUKINE 0,06 %, solution pour applica…ATC—REGISTER NO.FR:61649487PACKS LISTED3CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about solution d'hypochlorite de sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SOLUTION D'HYPOCHLORITE DE SODIUM
Manufacturer
GIFRER BARBEZAT
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

  • cip13
    3400933683443
    1 flacon(s) PVC de 200 ml
  • cip13
    3400933683504
    1 flacon(s) polyéthylène de 250 ml
  • cip13
    3400935515513
    1 flacon(s) PVC de 60 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Solution d'hypochlorite de sodium in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All solution d'hypochlorite de sodium products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Histolith, Hypochlorit Speiko
  • Italy · Amukine Med

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9f1d940-965f-439a-91fa-b7b64767c9a4
GET /v1/drugs/e9f1d940-965f-439a-91fa-b7b64767c9a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61649487",
  "date_amm": "1993-12-13",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SOLUTION D'HYPOCHLORITE DE SODIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour application",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about solution d'hypochlorite de sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console